From: Selenium Treatment and Chagasic Cardiopathy (STCC): study protocol for a double-blind randomized controlled trial
Parameters
Groups
Placebo (n= 65)
Selenium (n= 65)
Progression rate
54%
27%
Confidence level
95%
Proportion
1:1